Aug 13, 2026 7:30 am EDT Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
Aug 6, 2026 7:30 am EDT Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
Aug 3, 2026 7:30 am EDT Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 21, 2026 7:30 am EDT Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
Jul 1, 2026 7:30 am EDT Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 1, 2026 8:30 am EDT Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 26, 2026 8:30 am EDT Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
May 13, 2026 7:30 am EDT Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
May 11, 2026 8:30 am EDT Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®
